Literature DB >> 6393764

The Potter sequence: a clinical analysis of 80 cases.

C J Curry, K Jensen, J Holland, L Miller, B D Hall.   

Abstract

Eighty cases of Potter sequence due to a renal or urologic abnormality were studied retrospectively. The abnormal renal findings were bilateral renal agenesis in 21.25%; cystic dysplasia in 47.5%; obstructive uropathy in 25%; and others in 5.25%. Fifteen patients had multiple congenital anomalies; of these three had aneuploidy, four had autosomal recessive syndromes, and eight were of unknown cause. Results of chromosome analysis in 41 patients and 21 sets of parents were abnormal in three patients, one of whom had a balanced translocation carrier parent; two additional patients and three parents had apparently balanced translocations. There was one recurrence within the study (the first child had bilateral renal agenesis and the second cystic dysplasia). The ultrasound prenatal diagnosis of the renal abnormality was made in eight cases between 18 and 34 weeks. Family histories were suggestive of an autosomal dominant gene disorder with incomplete penetrance in four of 45 families with nonsyndromic bilateral renal agenesis and cystic dysplasia. The evaluation of patients with the Potter sequence should include an examination for nonrenal defects, autopsy, chromosome analysis, and renal ultrasound or urologic evaluation of parents. Ultrasonographic prenatal monitoring of subsequent pregnancies in such families is strongly warranted because of a definite but unknown degree of recurrence risk.

Entities:  

Mesh:

Year:  1984        PMID: 6393764     DOI: 10.1002/ajmg.1320190408

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  12 in total

1.  Is unilateral multicystic renal dysplasia sometimes heritable, and what is the risk of recurrence?

Authors:  J Bernstein
Journal:  Pediatr Nephrol       Date:  1990-11       Impact factor: 3.714

2.  Chromosome 22q11 deletion presenting as the Potter sequence.

Authors:  K Devriendt; P Moerman; D Van Schoubroeck; K Vandenberghe; J P Fryns
Journal:  J Med Genet       Date:  1997-05       Impact factor: 6.318

Review 3.  Renal development in the fetus and premature infant.

Authors:  Stacy Rosenblum; Abhijeet Pal; Kimberly Reidy
Journal:  Semin Fetal Neonatal Med       Date:  2017-02-01       Impact factor: 3.926

Review 4.  Posterior urethral valves in patients with Down syndrome.

Authors:  J C Kupferman; C L Stewart; F J Kaskel; R N Fine
Journal:  Pediatr Nephrol       Date:  1996-04       Impact factor: 3.714

5.  Bilateral renal agenesis/hypoplasia/dysplasia (BRAHD): postmortem analysis of 45 cases with breakpoint mapping of two de novo translocations.

Authors:  Louise Harewood; Monica Liu; Jean Keeling; Alan Howatson; Margo Whiteford; Peter Branney; Margaret Evans; Judy Fantes; David R Fitzpatrick
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

6.  Bilateral Optic Disc Anomalies Associated with PAX2 Mutation in a Case of Potter Sequence.

Authors:  Mizuki Tagami; Shigeru Honda; Ichiro Morioka; Masafumi Matsuo; Akira Negi
Journal:  Case Rep Ophthalmol       Date:  2010-11-29

7.  Potter sequence and consanguinity--a case report.

Authors:  B R Fischler; U B Berg
Journal:  Pediatr Nephrol       Date:  1994-02       Impact factor: 3.714

8.  Prune-belly anomalies in a girl with Down syndrome.

Authors:  Nafaa N Al Harbi
Journal:  Pediatr Nephrol       Date:  2003-09-12       Impact factor: 3.714

Review 9.  Genetics of cystic kidney diseases. Criteria for classification and genetic counselling.

Authors:  K Zerres
Journal:  Pediatr Nephrol       Date:  1987-07       Impact factor: 3.714

10.  An Amish founder variant consolidates disruption of CEP55 as a cause of hydranencephaly and renal dysplasia.

Authors:  Lettie E Rawlins; Hannah Jones; Olivia Wenger; Myat Aye; James Fasham; Gaurav V Harlalka; Barry A Chioza; Alexander Miron; Sian Ellard; Matthew Wakeling; Andrew H Crosby; Emma L Baple
Journal:  Eur J Hum Genet       Date:  2019-01-08       Impact factor: 4.246

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.